Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
If antidepressants have not helped, there are several factors to consider, including brain connectivity and plasticity changes, inflammation, stress hormone overactivity, genetics, and issues like misdiagnosis, dosing, or coexisting conditions; this pattern is often called treatment-resistant depression.
Ketamine offers a different medical path by acting on glutamate to rapidly rebuild synaptic communication, with options like monitored IV infusions and FDA-approved esketamine that help 50 to 70 percent of patients within hours to days, though maintenance and a full care plan are usually needed. See the essential safety criteria, contraindications, and when to seek urgent help below to choose the right next step with your clinician.
If you've tried antidepressants and still feel stuck, you are not alone. Up to one-third of people with major depressive disorder do not respond fully to their first medication. This is often called treatment-resistant depression.
It can feel discouraging. But it doesn't mean you're broken. And it doesn't mean nothing will work.
Understanding why your brain may resist traditional medications — and how newer treatments like ketamine for depression are changing care — can help you make informed decisions with your doctor.
Most traditional antidepressants (like SSRIs and SNRIs) work by adjusting levels of brain chemicals such as serotonin and norepinephrine. For many people, this helps.
But depression is more complex than just "low serotonin."
Research shows depression can involve:
Because of this complexity, some brains simply don't respond to medications that only target serotonin.
If you're uncertain whether your symptoms align with depression or something else, taking a free Depression symptom assessment can help you gain clarity on what you're experiencing and prepare meaningful questions before your next doctor's appointment.
Treatment-resistant depression (TRD) is generally defined as depression that has not improved after trying at least two different antidepressants at adequate doses and durations.
TRD does not mean your depression is permanent. It means your brain may need a different approach.
This is where ketamine for depression enters the conversation.
Ketamine has been used safely for decades as an anesthetic. In the past 20 years, research has shown that low doses of ketamine can rapidly improve symptoms of severe depression — even in people who have not responded to other treatments.
Unlike traditional antidepressants, ketamine works on a different brain system: glutamate.
Glutamate is the brain's main excitatory neurotransmitter and plays a key role in:
Instead of slowly adjusting serotonin levels, ketamine appears to:
This is very different from standard medications that may take 4–8 weeks to show benefits.
There are two primary medical uses of ketamine for depression:
Both approaches require supervision by trained professionals. Ketamine is not something to try outside medical care.
Clinical trials and real-world studies show:
It's important to understand: ketamine is not a permanent cure. For many patients, it acts as a powerful reset — creating a window of improvement that can be strengthened with therapy and ongoing care.
Most people describe the ketamine experience as:
These effects typically fade within 1–2 hours.
Clinics monitor:
You cannot drive yourself home afterward.
When used in medical settings under supervision, ketamine has been shown to be generally safe and well tolerated.
Possible side effects include:
Long-term safety data continues to be studied. This is why treatment is carefully controlled and monitored.
Ketamine is not recommended for people with:
This is why evaluation by a qualified doctor is essential.
One major reason ketamine for depression may work when SSRIs fail is that it targets brain connectivity, not just brain chemistry.
Depression has been linked to:
Ketamine appears to stimulate a pathway called BDNF (brain-derived neurotrophic factor), which promotes new neural growth and strengthens communication between brain cells.
In simple terms: it may help the brain rebuild pathways that depression has weakened.
That's fundamentally different from just adjusting serotonin levels.
You may want to discuss ketamine for depression with your doctor if:
It's not a first-line treatment for most people. But for some, it can be life-changing.
Ketamine works best when combined with:
Think of it as creating a window of opportunity. Therapy and healthy changes help sustain improvement.
If you are experiencing:
You need immediate medical care. Speak to a doctor, go to the nearest emergency department, or contact emergency services in your area.
Depression can be life-threatening. Early treatment matters.
If you're still depressed despite medication, it does not mean you've failed treatment. It may mean your brain needs a different approach.
Ketamine for depression represents one of the most significant advances in mental health treatment in decades. By targeting glutamate and promoting brain repair, it offers hope for people who haven't responded to traditional antidepressants.
It's not a miracle cure. It requires medical supervision. And it works best as part of a comprehensive treatment plan.
If you're questioning whether what you're experiencing is actually depression or need help identifying your symptoms, start by using this free Depression symptom checker to better understand your condition before consulting with a healthcare professional.
Most importantly, speak to a doctor about any persistent, severe, or life-threatening symptoms. Depression is treatable — even when it feels resistant.
You are not out of options.
(References)
* Bairwa M, Sharma B, Pahal P, Kaundal RK, Parray JA, Gupta G, Singh S, Alqahtani F, Altamimi MA, Ahmad Z, Kumar A. Pathophysiological Mechanisms of Treatment-Resistant Depression: A Comprehensive Review. Biomedicines. 2022 Jul 18;10(7):1709. doi: 10.3390/biomedicines10071709. PMID: 35882676.
* Bahji A, Vazquez G, Al-Owais A, Grollo H. Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Narrative Review. Psychiatr Ann. 2023 Feb;53(2):65-71. doi: 10.3928/00485713-20221206-02. PMID: 36767784.
* Zhang J, Wei Y, Huang Y, Huang M, Yu Q, Lin X. Ketamine and its derivatives in treatment-resistant depression: a comprehensive review of clinical efficacy, safety, and mechanisms of action. Front Psychiatry. 2023 Jun 14;14:1189433. doi: 10.3389/fpsyt.2023.1189433. PMID: 37375685.
* Waseem Z, Yuen AW, Park J, Ng L, Luong A, Lu W, Su K, Wu J, Ma D, Li Q. The Neurobiology of Treatment-Resistant Depression: Focus on Inflammation, Stress, and Mitochondrial Dysfunction. Int J Mol Sci. 2023 Mar 24;24(7):6118. doi: 10.3390/ijms24076118. PMID: 36986289.
* Abdallah CG, Adams TG, Coplan JD, Lim R, Lim S, Mao X, Mathew SJ, Orellana R, Singh S. NMDA receptor modulators for the treatment of depression. Psychiatr Ann. 2023 Feb;53(2):77-83. doi: 10.3928/00485713-20221206-04. PMID: 36767798.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.